Dr. Sunil Singhal

Get to Know Dr. Sunil Singhal

Dr. Sunil Singhal is a thoracic surgeon who specializes in cancers of the lung and esophagus, mediastinal disease and pleural mesothelioma.

Singhal has been lauded for his innovative research efforts after starting the Thoracic Surgery Research Laboratory at the University of Pennsylvania Perelman School of Medicine in 2007.

Under his direction, the laboratory has helped advance strategies for mesothelioma treatment and several other thoracic cancers, making groundbreaking discoveries in molecular biology, immunotherapy, nanotechnology and gene therapy. The laboratory has been awarded grants regularly from the National Institutes of Health.

He plays a key role in Penn Medicine’s Lung Cancer program and Mesothelioma and Pleural Disease program. Both are multidisciplinary efforts that ensure patients are receiving the very best care.

Singhal, who serves as an assistant professor of surgery at the school, also is chief of thoracic surgery at the nearby Philadelphia VA Medical Center.

Specialties of Dr. Sunil Singhal

• Mediastinal disease
• Lung cancer
• Pleural mesothelioma
• Chest wall resection
• Minimally invasive surgery
• Bronchoscopy
• Barrett’s esophagus
• Malignant effusion

Dr. Sunil Singhal’s Experience and Medical Education

• University of Pennsylvania School of Medicine
• Hospital of the University of Pennsylvania (Fellowship)
• Johns Hopkins Hospital (Residency)
• University of Pennsylvania School of Medicine (M.D.)

Awards and Certifications

• Cell & Molecular Biology Graduate Group
• Vice Chair of Translational Research
• Society of Surgical Oncology
• Veterans Administration, Grant Review Board
• The International Society for Heart and Lung Transplantation

Publications of Dr. Sunil Singhal

• Predina, J. et al. (2019, May). Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas. Journal of Thoracic Cardiovascular Surgery.
• Predina, J. et al. (2018, July). Localization of Pulmonary Ground-Glass Opacities with Folate Receptor-Targeted Intraoperative Molecular Imaging. Journal of Thoracic Oncology.
• Keating, J. et al. (2016, April). Intraoperative Molecular Imaging of Lung Adenocarcinoma Can Identify Residual Tumor Cells at the Surgical Margins. Molecular Imaging and Biology.
• Singhal, S. et al. (2010). Nanotechnology applications in surgical oncology. Annual Review of Medicine.